Refractory Hurthle Cell Thyroid Cancer
1 clinical trials · Condition
◉ Watch Refractory Hurthle Cell Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer (NCT02143726) | Alliance for Clinical Trials in Oncology | 2014-10-09 |
Track Refractory Hurthle Cell Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.